Episode Details

We're going behind the curtain of skincare innovation with Giselle, Chief Brand & Innovation Officer at Alumier MD. With 22 years in the industry, she breaks down how a product actually goes from idea to shelf (12 to 24 months), how to spot a real clinical study versus a marketing stunt, and why the word "longevity" has become almost meaningless.

We also run through the hottest ingredients in skincare right now — exosomes, PDRN/salmon DNA, growth factors, peptides, senescent ("zombie") cells — and get Giselle's honest verdict on what's real, what's promising, and what's mostly hype.

Plus: the concept of "oxidative aging," why more stimulation doesn't mean better results, and the "core four" essentials every routine needs regardless of budget.

🎙️ Guests: 

Giselle Curcio: https://www.linkedin.com/in/giselle-disanto-0228a355/

💻 Book a virtual consultation with Boutique Skin Envie: https://bskinenvie.ca/

🛍️ Use code SKINTALKS15 for 15% off your first order

Connect With Us:

Hosts:

Beate Instagram → @beatevonhuene

Natascha Instagram → @nataschaschillinger

Our Website:

🌐 https://bskinenvie.ca/

Stay Connected:

New episodes every Wednesday

📱 Instagram → @skintalkspod

00:00 Intro

01:01 Who is Giselle and her role at Alumier MD

04:47 From idea to product: the innovation process

10:09 How to spot a real clinical study

13:15 Anti-aging vs longevity: just a rebrand?

20:36 The biology of skin: what you can control (and can't)

26:43 Oxidative aging explained

30:52 The verdict on hyped ingredients

40:52 Too much stimulation can damage your skin

44:49 The "core four": non-negotiable essentials

50:19 Final rapid fire